Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
ATLANTA, GA--(Marketwired - May 23, 2016) - Celtaxsys, Inc., a clinical stage pharmaceutical company focused on developing anti-inflammatory therapies for cystic fibrosis (CF) lung disease and...
-
ATLANTA, GA--(Marketwired - May 03, 2016) - Celtaxsys, a clinical stage drug development company focused on advancing therapies for patients with rare and orphan inflammatory diseases, announced...
-
ATLANTA, GA--(Marketwired - December 01, 2015) - Celtaxsys, a clinical stage drug development company focused on advancing foundational medicine for patients suffering from orphan inflammatory...
-
ATLANTA, GA--(Marketwired - October 01, 2015) - Celtaxsys, a clinical stage drug development company focused on advancing care for patients suffering from orphan inflammatory diseases, announced today...